BillionToOne Alternatives & Competitors
12 companies similar to BillionToOne — We push the boundaries of molecular diagnostics through quantitative technologie...
Companies similar to BillionToOne
Molecular Testing Labs
Powering Health Diagnostics
Vancouver, United States
EMPE Diagnostics
Confirmatory precision diagnostics for tuberculosis (MDR/XDR-TB) within 3 h even at resour...
Solna, Sweden
CellScape
Bringing accessible, non-invasive prenatal genetic testing to every woman through pioneeri...
Exosome Diagnostics, a Bio-Techne brand
ExoDx Prostate is the only exosome-based, non-DRE, simple urine test to assess risk for HG...
Waltham, United States
Rival Readout
Competing with BillionToOne? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
-logo.jpg "ENDRA Life Sciences (Nasdaq: NDRA)"){kind=logo}
ENDRA Life Sciences (Nasdaq: NDRA)
Focused on early detection of liver disease
Ann Arbor, United States
AeenaDx
The future...at home saliva self-collection for the detection of cancers and disease
Mountain View, United Sta...
Apostle Inc
Apostle is a provider of innovative technologies and services for public health and life s...
Pleasanton, United States
Lophius Biosciences GmbH
Our mission is to transform treatment paradigms and patient management with novel molecula...
Regensburg, Germany
PreCyte Inc
Envisioning a world free from cancer and neurodegenerative disease
Seattle, United States
Cyted Health
Transforming access to digestive health for everyone, everywhere.
Cambridge, United Kingdom
Engine Biosciences
Deciphering Biological Complexity to Unleash Many Impactful Medicines
Singapore, Singapore
About BillionToOne
BillionToOne, founded in 2016, is a pioneering entity in the Biotechnology and Health Care industries, headquartered in the United States. The company is renowned for its commitment to enhancing the accuracy, efficiency, and accessibility of molecular diagnostics, encapsulated in their slogan: "We push the boundaries o...
Development and provision of advanced diagnostic tests, Quantification of disease-causing DNA fragments, Non-invasive prenatal and oncology testing solutions, Monitoring treatment response in cancer patients
Healthcare Providers, Pregnant Women, Oncologists, Medical Researchers
Molecular Diagnostics, Precision Diagnostics, DNA Quantification, Molecular Counting Technology, Disease Detection, Prenatal Testing, Single-gene Disorder Detection, Non-invasive Testing, Blood Test Innovation, Affordable Healthcare Solutions, Patent-pending Technology, Risk Reduction In Diagnostics, Biotechnology Innovation
B2B, D2C, B2D
Service Fee, Usage Based, Transaction Fee
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around BillionToOne: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at BillionToOne on 9 Jun 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 2 Sep 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
